No profile data available.
Rapport Therapeutics, Inc. (RAPP) is a healthcare company in the brain and nerve treatment drugs industry, based in Boston, United States, with about 84 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$111.48 million. Its market capitalization was $1.47 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.
Rapport Therapeutics reported $0 in revenue for fiscal year 2025.
$1.47 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Biohaven Ltd. (BHVN), Compass Pathways plc (CMPS), Stoke Therapeutics, Inc. (STOK), Taysha Gene Therapies, Inc. (TSHA).